Development of a ‘ready-to-use’ tool that includes preventability, for the assessment of adverse drug events in oncology

Overview of attention for article published in International Journal of Clinical Pharmacy, February 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 6 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 44 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 9,254 followers.

RT @PVpapers: Development of a ‘ready-to-use’ tool that includes preventability, for the assessment of #AdverseDrugEvents in #oncology ht…

05 Mar 2018

Reply Repost Favourite

RT @je_pala: Development of a ‘ready-to-use’ tool that includes preventability, for the assessment of adverse drug events in #oncology http…

05 Mar 2018

Reply Repost Favourite

Development of a ‘ready-to-use’ tool that includes preventability, for the assessment of adverse drug events in #oncology https://t.co/RH1NjE7o0v from International Journal of Clinical Pharmacy #PtSafety

04 Mar 2018

Reply Repost Favourite

RT @PVpapers: Development of a ‘ready-to-use’ tool that includes preventability, for the assessment of #AdverseDrugEvents in #oncology ht…

03 Mar 2018

Reply Repost Favourite

Suena muy bien #segpac # PatSafety https://t.co/IinDkq1Qvx

03 Mar 2018

Reply Repost Favourite

Development of a ‘ready-to-use’ tool that includes preventability, for the assessment of #AdverseDrugEvents in #oncology https://t.co/Hos6eiP4LF

03 Mar 2018

Reply Repost Favourite